Literature DB >> 31871095

Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.

Souwelimatou Amadou Amani1, Tyler Shadid1, Jimmy D Ballard1, Mark L Lang2.   

Abstract

The intracellularly active bacterial toxin TcdB is a major Clostridioides difficile virulence factor that contributes to inflammation and tissue damage during disease. Immunization with an inactive TcdB fragment prevents C. difficile infection (CDI)-associated pathology. The protective immune response against inactive TcdB involves development of antigen-specific memory B cells and long-lived plasma cells that encode TcdB-neutralizing antibodies. Unlike the response to inactive TcdB, very little is known about the host humoral immune response to C. difficile and TcdB during primary and recurrent infection. Here, we used a murine model of C. difficile disease recurrence to demonstrate that an initial infection induced a serum IgM and mucosal IgA response against the toxin, but a low serum IgG response, which is associated with a lack of protection against disease during reinfection. Infection induced a partial expansion of the T follicular helper cell compartment, essential for B cell memory responses, and, consistent with that, failed to significantly expand the memory B cell compartment. Further, infection failed to stimulate the memory B cell compartment in preimmunized mice, although they were protected against associated disease. These results delineate the key humoral immune events that follow primary and recurrent C. difficile infection and provide a compelling inverse correlation between B cell memory and disease recurrence.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Clostridioides difficilezzm321990; humoral immunity; memory B cell; plasma cell; toxin

Mesh:

Substances:

Year:  2020        PMID: 31871095      PMCID: PMC7035940          DOI: 10.1128/IAI.00829-19

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

Review 1.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

2.  Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291.

Authors:  Jenessa A Winston; Rajani Thanissery; Stephanie A Montgomery; Casey M Theriot
Journal:  J Vis Exp       Date:  2016-12-10       Impact factor: 1.355

3.  Humoral immune response as predictor of recurrence in Clostridium difficile infection.

Authors:  M P Bauer; P H Nibbering; I R Poxton; E J Kuijper; J T van Dissel
Journal:  Clin Microbiol Infect       Date:  2014-12-12       Impact factor: 8.067

Review 4.  Toxin A-negative, toxin B-positive Clostridium difficile.

Authors:  Denise Drudy; Séamus Fanning; Lorraine Kyne
Journal:  Int J Infect Dis       Date:  2006-07-20       Impact factor: 3.623

5.  The role of toxin A and toxin B in Clostridium difficile infection.

Authors:  Sarah A Kuehne; Stephen T Cartman; John T Heap; Michelle L Kelly; Alan Cockayne; Nigel P Minton
Journal:  Nature       Date:  2010-09-15       Impact factor: 49.962

6.  Anthrax toxins inhibit immune cell chemotaxis by perturbing chemokine receptor signalling.

Authors:  Silvia Rossi Paccani; Fiorella Tonello; Laura Patrussi; Nagaja Capitani; Morena Simonato; Cesare Montecucco; Cosima T Baldari
Journal:  Cell Microbiol       Date:  2006-11-03       Impact factor: 3.715

7.  Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI).

Authors:  Brett A Leav; Barbra Blair; Mark Leney; Michael Knauber; Courtney Reilly; Israel Lowy; Dale N Gerding; Ciarán P Kelly; Kia Katchar; Roger Baxter; Donna Ambrosino; Deborah Molrine
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

8.  Specific humoral immunity in the elderly: in vivo and in vitro response to vaccination.

Authors:  E A Burns; L G Lum; G L'Hommedieu; J S Goodwin
Journal:  J Gerontol       Date:  1993-11

Review 9.  The cystic fibrosis intestine.

Authors:  Robert C De Lisle; Drucy Borowitz
Journal:  Cold Spring Harb Perspect Med       Date:  2013-09-01       Impact factor: 6.915

Review 10.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

View more
  7 in total

1.  A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory Clostridioides difficile Infection.

Authors:  Tanya M Monaghan; Niharika A Duggal; Elisa Rosati; Ruth Griffin; Jamie Hughes; Brandi Roach; David Y Yang; Christopher Wang; Karen Wong; Lynora Saxinger; Maja Pučić-Baković; Frano Vučković; Filip Klicek; Gordan Lauc; Paddy Tighe; Benjamin H Mullish; Jesus Miguens Blanco; Julie A K McDonald; Julian R Marchesi; Ning Xue; Tania Dottorini; Animesh Acharjee; Andre Franke; Yingrui Li; Gane Ka-Shu Wong; Christos Polytarchou; Tung On Yau; Niki Christodoulou; Maria Hatziapostolou; Minkun Wang; Lindsey A Russell; Dina H Kao
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

2.  Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies.

Authors:  Hemangi B Shah; Kenneth Smith; Edgar J Scott; Jason L Larabee; Judith A James; Jimmy D Ballard; Mark L Lang
Journal:  JCI Insight       Date:  2020-08-20

Review 3.  Host Immune Responses to Clostridioides difficile: Toxins and Beyond.

Authors:  Britt Nibbering; Dale N Gerding; Ed J Kuijper; Romy D Zwittink; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2021-12-21       Impact factor: 5.640

4.  Use of a Clostridioides difficile Murine Immunization and Challenge Model to Evaluate Single and Combination Vaccine Adjuvants Consisting of Alum and NKT Cell-Activating Ligands.

Authors:  Gillian A Lang; Kaylee Norman; Souwelimatou Amadou Amani; Tyler M Shadid; Jimmy D Ballard; Mark L Lang
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

5.  The Murine Neonatal Fc Receptor Is Required for Transport of Immunization-Induced C. difficile-Specific IgG to the Gut and Protection against Disease but Does Not Affect Disease Susceptibility.

Authors:  Souwelimatou Amadou Amani; Gillian A Lang; Jimmy D Ballard; Mark L Lang
Journal:  Infect Immun       Date:  2021-06-07       Impact factor: 3.441

Review 6.  Bacteria That Cause Enteric Diseases Stimulate Distinct Humoral Immune Responses.

Authors:  Souwelimatou Amadou Amani; Mark L Lang
Journal:  Front Immunol       Date:  2020-09-16       Impact factor: 7.561

7.  Pathobionts: mechanisms of survival, expansion, and interaction with host with a focus on Clostridioides difficile.

Authors:  Harish Chandra; Krishna Kant Sharma; Olli H Tuovinen; Xingmin Sun; Pratyoosh Shukla
Journal:  Gut Microbes       Date:  2021 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.